• Consensus Rating: Hold
  • Consensus Price Target: $50.38
  • Forecasted Upside: 23.47%
  • Number of Analysts: 14
  • Breakdown:
  • 0 Sell Ratings
  • 9 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
▲ +0.42 (1.04%)

This chart shows the closing price for PFE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Pfizer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PFE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PFE

Analyst Price Target is $50.38
▲ +23.47% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for Pfizer in the last 3 months. The average price target is $50.38, with a high forecast of $75.00 and a low forecast of $40.00. The average price target represents a 23.47% upside from the last price of $40.80.

This chart shows the closing price for PFE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 14 investment analysts is to hold stock in Pfizer. This rating has held steady since December 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 9 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 8 buy ratings
  • 11 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 12 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 11 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 11 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 8 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 9 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 9 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/17/2023Wells Fargo & CompanyLower TargetEqual Weight$50.00 ➝ $44.00Low
3/14/2023UBS GroupSet Target$45.00Low
3/6/2023Jefferies Financial GroupInitiated CoverageHold$43.00Low
2/28/2023UBS GroupSet Target$45.00Low
2/27/2023JPMorgan Chase & Co.Set Target$45.00Low
2/7/2023Berenberg BankSet Target$40.00Low
2/7/2023Daiwa Capital MarketsUpgradeNeutral ➝ Outperform$51.00Low
2/1/2023UBS GroupSet Target$45.00Low
2/1/2023Morgan StanleyLower TargetEqual Weight$53.00 ➝ $45.00Low
2/1/2023Cantor FitzgeraldReiterated RatingOverweight$75.00Low
2/1/2023SVB LeerinkLower TargetMarket Perform$49.00 ➝ $48.00Low
2/1/2023Atlantic SecuritiesLower TargetNeutral$50.00 ➝ $46.00Low
2/1/2023BMO Capital MarketsLower TargetOutperform$55.00 ➝ $53.00Low
2/1/2023Credit Suisse GroupLower TargetOutperform$54.00 ➝ $50.00Low
2/1/2023BarclaysLower TargetEqual Weight$49.00 ➝ $44.00Low
1/31/2023JPMorgan Chase & Co.Set Target$50.00Low
1/26/2023UBS GroupDowngradeBuy ➝ Neutral$55.00 ➝ $47.00Low
1/18/2023UBS GroupSet Target$55.00Low
1/18/2023Credit Suisse GroupSet Target$54.00Low
1/18/2023JPMorgan Chase & Co.Set Target$50.00Low
1/17/2023Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$54.00 ➝ $50.00Low
1/10/2023JPMorgan Chase & Co.Set Target$50.00Low
1/4/2023Bank of AmericaDowngradeBuy ➝ Neutral$60.00Low
12/14/2022Morgan StanleyBoost TargetEqual Weight$51.00 ➝ $53.00Low
12/13/2022Credit Suisse GroupSet Target$55.00Low
12/13/2022The Goldman Sachs GroupUpgradeNeutral ➝ Buy$47.00 ➝ $60.00Low
12/6/2022Credit Suisse GroupSet Target$55.00Low
11/23/2022Credit Suisse GroupSet Target$55.00Low
11/17/2022Credit Suisse GroupInitiated CoverageOutperform$55.00Low
11/8/2022The Goldman Sachs GroupSet Target$47.00Low
11/3/2022SVB LeerinkBoost TargetMarket Perform$48.00 ➝ $49.00Low
11/3/2022UBS GroupSet Target$55.00Low
11/2/2022Wells Fargo & CompanyLower TargetOverweight$55.00 ➝ $54.00Low
11/2/2022Morgan StanleyBoost TargetEqual Weight$50.00 ➝ $51.00Low
11/2/2022BarclaysBoost TargetEqual Weight$44.00 ➝ $49.00Low
11/1/2022JPMorgan Chase & Co.Set Target$50.00Low
10/17/2022The Goldman Sachs GroupSet Target$48.00Low
10/12/2022Morgan StanleyBoost TargetEqual Weight$49.00 ➝ $50.00Low
10/12/2022BarclaysLower TargetEqual Weight$50.00 ➝ $44.00Low
10/11/2022JPMorgan Chase & Co.Set Target$50.00Low
10/11/2022SVB LeerinkLower TargetMarket Perform ➝ Market Perform$53.00 ➝ $48.00Low
9/14/2022Berenberg BankSet Target$44.00Low
9/1/2022The Goldman Sachs GroupSet Target$50.00Low
9/1/2022UBS GroupSet Target$59.00Low
9/1/2022BarclaysSet Target$50.00Low
8/26/2022The Goldman Sachs GroupSet Target$50.00Low
8/26/2022UBS GroupSet Target$59.00Low
8/26/2022BarclaysSet Target$50.00Low
8/9/2022BarclaysBoost Target$52.00Low
8/1/2022BarclaysBoost TargetEqual Weight$50.00 ➝ $52.00Low
7/29/2022The Goldman Sachs GroupSet Target$50.00Low
7/29/2022SVB LeerinkLower TargetMarket Perform$55.00 ➝ $53.00Low
7/13/2022The Goldman Sachs GroupSet Target$51.00Low
7/8/2022Morgan StanleyLower TargetEqual Weight$52.00 ➝ $49.00N/A
7/7/2022BarclaysSet Target$52.00N/A
6/28/2022JPMorgan Chase & Co.Set Target$57.00Low
6/27/2022BarclaysSet Target$52.00Low
5/27/2022Berenberg BankSet Target$50.00Low
5/25/2022The Goldman Sachs GroupSet Target$51.00Low
5/23/2022SVB LeerinkInitiated CoverageMarket Perform$55.00Low
5/19/2022Berenberg BankSet Target$50.00High
5/17/2022BarclaysSet Target$52.00Low
5/4/2022BarclaysSet Target$52.00Medium
5/4/2022The Goldman Sachs GroupSet Target$51.00Medium
5/4/2022Wells Fargo & CompanyLower Target$60.00 ➝ $55.00Low
5/3/2022JPMorgan Chase & Co.Set Target$57.00Low
4/21/2022Berenberg BankSet Target$50.00Medium
4/6/2022Morgan StanleyInitiated CoverageEqual Weight$55.00Medium
4/5/2022CitigroupBoost TargetNeutral$46.00 ➝ $57.00N/A
2/10/2022Morgan StanleyLower TargetEqual Weight$60.00 ➝ $55.00Medium
2/10/2022MizuhoLower Target$56.00 ➝ $55.00Medium
2/9/2022BarclaysSet Target$54.00Low
2/8/2022JPMorgan Chase & Co.Set Target$57.00Low
2/8/2022The Goldman Sachs GroupSet TargetNeutral$51.00 ➝ $54.00Low
1/28/2022JPMorgan Chase & Co.Boost TargetNeutral$53.00 ➝ $57.00Low
1/14/2022BMO Capital MarketsBoost Target$60.00 ➝ $76.00Low
1/11/2022BarclaysSet Target$54.00Low
1/10/2022The Goldman Sachs GroupSet Target$51.00Low
1/7/2022Wells Fargo & CompanyBoost TargetOverweight$60.00 ➝ $65.00Low
1/5/2022Bank of AmericaUpgradeNeutral ➝ Buy$59.00 ➝ $70.00Low
1/4/2022The Goldman Sachs GroupSet Target$51.00High
1/4/2022BarclaysSet Target$54.00High
1/3/2022Sanford C. BernsteinBoost TargetMarket Perform$44.00 ➝ $65.00Medium
12/29/2021The Goldman Sachs GroupSet Target$51.00High
12/29/2021BarclaysSet Target$54.00High
12/23/2021BarclaysSet Target$54.00High
12/23/2021The Goldman Sachs GroupSet Target$51.00Medium
12/20/2021CowenBoost TargetOutperform ➝ Outperform$56.00 ➝ $70.00Medium
12/17/2021The Goldman Sachs GroupInitiated CoverageNeutral$51.00High
12/16/2021BarclaysSet Target$54.00High
12/15/2021SVB LeerinkBoost TargetMarket Perform$52.00 ➝ $56.00High
12/14/2021MizuhoBoost TargetNeutral ➝ Neutral$44.00 ➝ $56.00High
12/14/2021Berenberg BankReiterated RatingHold$54.00Medium
12/13/2021JPMorgan Chase & Co.Set Target$53.00Low
12/13/2021UBS GroupUpgradeNeutral ➝ Buy$52.00 ➝ $60.00High
12/10/2021BarclaysBoost TargetEqual Weight ➝ Equal Weight$44.00 ➝ $54.00High
12/8/2021Wells Fargo & CompanyInitiated CoverageOverweight$60.00Medium
11/29/2021JPMorgan Chase & Co.Boost TargetNeutral$42.00 ➝ $53.00High
11/29/2021Morgan StanleyBoost TargetSell ➝ Equal Weight$50.00 ➝ $60.00High
11/24/2021Truist FinancialBoost TargetBuy$43.00 ➝ $58.00Low
11/18/2021BMO Capital MarketsInitiated CoverageOutperform$60.00High
11/17/2021BarclaysSet Target$44.00High
11/11/2021Independent ResearchUpgradeBuy$53.00Low
11/5/2021Cantor FitzgeraldReiterated RatingBuy$60.00Low
11/5/2021BenchmarkBoost TargetBuy$29.00 ➝ $45.00Low
11/5/2021JPMorgan Chase & Co.Set Target$42.00High
11/3/2021BarclaysSet Target$44.00Medium
11/3/2021SVB LeerinkLower TargetMarket Perform$50.00 ➝ $48.00High
10/12/2021Morgan StanleyBoost TargetEqual Weight$45.00 ➝ $48.00Low
10/3/2021MizuhoReiterated RatingHold$43.00Medium
9/20/2021SVB LeerinkBoost TargetMarket Perform$49.00 ➝ $50.00High
9/14/2021SVB LeerinkReiterated RatingHold$49.00Low
9/13/2021JPMorgan Chase & Co.Boost TargetNeutral$40.00 ➝ $42.00High
7/30/2021MizuhoBoost TargetNeutral$42.00 ➝ $43.00Low
7/29/2021The Goldman Sachs GroupSet Target$48.00Low
7/29/2021Morgan StanleyBoost TargetEqual Weight$42.00 ➝ $45.00Low
7/29/2021Royal Bank of CanadaSet Target$44.00Low
7/29/2021SVB LeerinkBoost TargetMarket Perform$47.00 ➝ $49.00Low
7/27/2021Truist FinancialInitiated CoverageBuy$43.00High
6/17/2021Royal Bank of CanadaBoost TargetSector Perform$43.00 ➝ $44.00Low
6/15/2021Berenberg BankReiterated RatingNeutral$43.00Low
5/24/2021JPMorgan Chase & Co.Set TargetNeutral$40.00Low
5/24/2021The Goldman Sachs GroupSet TargetNeutral$45.00Low
5/13/2021The Goldman Sachs GroupReiterated RatingNeutral$45.11Low
5/12/2021MizuhoReiterated RatingBuy ➝ Neutral$42.00Low
5/10/2021Morgan StanleyBoost TargetEqual Weight$38.00 ➝ $42.00Low
5/6/2021MizuhoDowngradeBuy ➝ Neutral$42.00Low
5/5/2021SVB LeerinkBoost TargetMarket Perform$39.00 ➝ $43.00High
5/5/2021JPMorgan Chase & Co.Boost TargetNeutral$36.00 ➝ $40.00Medium
5/5/2021BarclaysBoost TargetEqual Weight$37.00 ➝ $40.00Medium
4/7/2021Royal Bank of CanadaInitiated CoverageSector Perform$42.00Low
4/6/2021The Goldman Sachs GroupSet TargetNeutral$41.00Low
3/31/2021The Goldman Sachs GroupSet TargetNeutral$41.00Low
3/26/2021SVB LeerinkLower TargetMarket Perform$40.00 ➝ $39.00Medium
3/23/2021Berenberg BankReiterated RatingNeutral$38.00Medium
3/15/2021The Goldman Sachs GroupSet TargetNeutral$41.00Medium
3/9/2021The Goldman Sachs GroupReiterated RatingNeutral$41.00Low
2/3/2021JPMorgan Chase & Co.Set TargetNeutral$36.00Low
2/3/2021DZ BankReiterated RatingHold ➝ Buy$41.00Low
2/3/2021SVB LeerinkLower TargetMarket Perform$44.00 ➝ $40.00Low
2/3/2021MizuhoLower TargetBuy$44.00 ➝ $42.00Low
1/29/2021Morgan StanleyLower TargetEqual Weight$40.00 ➝ $38.00Medium
1/21/2021The Goldman Sachs GroupSet TargetNeutral$40.00Low
1/8/2021The Goldman Sachs GroupSet TargetNeutral$40.00Low
1/4/2021Royal Bank of CanadaSet TargetNeutral$42.00N/A
12/29/2020Royal Bank of CanadaReiterated RatingNeutral$42.00N/A
12/16/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$43.00 ➝ $42.00N/A
12/11/2020The Goldman Sachs GroupSet TargetNeutral$40.00Low
12/4/2020BarclaysBoost TargetEqual Weight$35.00 ➝ $37.00Low
12/2/2020BarclaysSet TargetNeutral$35.00Medium
12/2/2020Royal Bank of CanadaSet TargetBuy$43.00Low
12/2/2020The Goldman Sachs GroupSet TargetNeutral$40.00Low
11/19/2020The Goldman Sachs GroupInitiated CoverageNeutral$40.00Medium
11/10/2020Sanford C. BernsteinInitiated CoverageMarket Perform$42.00High
11/10/2020MizuhoBoost TargetBuy$43.00 ➝ $44.00High
11/9/2020BarclaysReiterated RatingNeutral$35.00High
11/9/2020JPMorgan Chase & Co.Set TargetNeutral$36.00High
10/28/2020SVB LeerinkBoost TargetMarket Perform$42.00 ➝ $43.00High
10/23/2020Truist FinancialInitiated CoverageBuy$42.00Low
10/16/2020Royal Bank of CanadaSet TargetBuy$43.00Low
10/12/2020Atlantic SecuritiesDowngradeOverweight ➝ Neutral$44.00 ➝ $39.00Low
9/29/2020Berenberg BankInitiated CoverageHold$38.00Low
9/15/2020MizuhoReiterated RatingBuy$43.00Low
9/9/2020Royal Bank of CanadaSet TargetBuy$43.00Low
7/30/2020Morgan StanleyBoost TargetEqual Weight$36.00 ➝ $42.00Low
7/29/2020UBS GroupBoost TargetNeutral$37.00 ➝ $39.00Low
7/29/2020SVB LeerinkBoost TargetMarket Perform$39.00 ➝ $42.00Low
7/28/2020MizuhoReiterated RatingPositive ➝ Buy$38.00Low
7/21/2020Morgan StanleyReiterated RatingHold$36.00High
7/20/2020Royal Bank of CanadaReiterated RatingBuy$43.00High
6/29/2020MizuhoInitiated CoverageBuy$38.00Low
6/26/2020Piper SandlerBoost Target$18.50 ➝ $24.00Medium
6/16/2020SVB LeerinkInitiated CoverageMarket Perform$40.00Low
6/1/2020BarclaysLower Target$37.00 ➝ $35.00Medium
6/1/2020JPMorgan Chase & Co.Lower TargetNeutral$37.00 ➝ $36.00High
5/18/2020MizuhoReiterated RatingBuy$42.00Low
4/29/2020BarclaysBoost TargetEqual Weight$36.00 ➝ $37.00Low
4/27/2020Royal Bank of CanadaReiterated RatingBuy$44.00Medium
4/26/2020MizuhoReiterated RatingBuy$42.00High
4/2/2020Morgan StanleyLower TargetEqual Weight$43.00 ➝ $36.00Medium
3/27/2020Royal Bank of CanadaLower TargetOutperform$46.00 ➝ $44.00Low
3/19/2020Cantor FitzgeraldReiterated RatingBuy$53.00High
3/18/2020MizuhoReiterated RatingBuy$42.00High
2/27/2020Standpoint ResearchUpgradeHold ➝ BuyHigh
2/27/2020BarclaysInitiated CoverageEqual Weight$36.00Medium
2/5/2020MizuhoInitiated CoverageBuy$42.00Low
1/29/2020Cantor FitzgeraldReiterated RatingBuy$53.00Low
1/28/2020JPMorgan Chase & Co.Reiterated RatingNeutral$37.00Low
1/6/2020Royal Bank of CanadaInitiated CoverageOutperform$46.00Medium
11/6/2019Credit Suisse GroupReiterated RatingHold$41.30Low
10/29/2019JPMorgan Chase & Co.Reiterated RatingNeutralHigh
10/16/2019Bank of AmericaInitiated CoverageNeutral$37.00Low
9/19/2019JPMorgan Chase & Co.Boost TargetNeutral$37.00 ➝ $46.00Low
8/28/2019DZ BankUpgradeSell ➝ Hold$36.00Medium
8/27/2019Morgan StanleyLower TargetEqual Weight$40.00 ➝ $38.00High
8/27/2019DZ BankReiterated RatingHold ➝ NeutralMedium
8/12/2019Credit Suisse GroupReiterated RatingHold ➝ NeutralHigh
8/5/2019UBS GroupReiterated RatingNeutral$43.00High
7/30/2019Bank of AmericaDowngradeBuy ➝ NeutralHigh
7/30/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$48.00 ➝ $40.00High
7/29/2019JPMorgan Chase & Co.Set TargetNeutral$46.00High
7/23/2019JPMorgan Chase & Co.Reiterated RatingNeutral$46.00Low
7/15/2019Credit Suisse GroupInitiated CoverageHold$47.00Low
6/17/2019Credit Suisse GroupReiterated RatingBuy$48.00Low
6/17/2019The Goldman Sachs GroupReiterated RatingBuy$49.00Low
6/17/2019JPMorgan Chase & Co.Reiterated RatingHold$46.00Low
6/4/2019Morgan StanleyInitiated CoverageOverweight ➝ Overweight$48.00Low
5/28/2019The Goldman Sachs GroupInitiated CoverageConviction-BuyLow
5/9/2019BarclaysReiterated RatingHold$41.00Low
5/6/2019Credit Suisse GroupReiterated RatingBuy$48.00Medium
4/30/2019JPMorgan Chase & Co.Set TargetNeutral$46.00Low
4/19/2019JPMorgan Chase & Co.Reiterated RatingNeutral$46.00N/A
4/1/2019Bank of AmericaBoost TargetBuy ➝ Buy$45.00 ➝ $48.00Low
2/20/2019CitigroupReiterated RatingSell ➝ Neutral$41.00Medium
2/19/2019Cantor FitzgeraldReiterated RatingBuy$53.00Low
1/31/2019ArgusUpgradeHold ➝ Buy$55.00Medium
1/31/2019Credit Suisse GroupUpgradeNeutral ➝ OutperformMedium
1/28/2019Credit Suisse GroupReiterated RatingNeutral$45.00High
1/23/2019UBS GroupDowngradeBuy ➝ NeutralLow
1/1/2019Credit Suisse GroupSet TargetNeutral$45.00Medium
12/30/2018Cantor FitzgeraldSet TargetBuy$53.00Low
12/26/2018Credit Suisse GroupSet TargetNeutral$45.00High
12/20/2018Credit Suisse GroupReiterated RatingNeutral$45.00Low
12/13/2018Credit Suisse GroupSet TargetHold$45.00Medium
12/11/2018Cantor FitzgeraldReiterated RatingBuy$53.00Low
12/11/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$46.00Low
11/27/2018Atlantic SecuritiesReiterated RatingBuy$54.00Medium
11/26/2018Credit Suisse GroupSet TargetHold$42.00Medium
11/19/2018Cantor FitzgeraldReiterated RatingBuy$53.00Low
11/8/2018Cantor FitzgeraldSet TargetBuy$53.00Low
11/6/2018CitigroupBoost TargetSell ➝ Sell$34.00 ➝ $37.00Medium
11/1/2018BMO Capital MarketsDowngradeOutperform ➝ Market Perform$47.00 ➝ $46.00Medium
11/1/2018Societe GeneraleSet TargetHold$43.00Medium
10/30/2018Credit Suisse GroupReiterated RatingNeutral ➝ Neutral$40.00Low
10/30/2018The Goldman Sachs GroupReiterated RatingNeutral$45.00Low
10/30/2018JPMorgan Chase & Co.Reiterated RatingBuyLow
10/23/2018Wolfe ResearchInitiated CoverageMarket PerformLow
10/19/2018BarclaysSet TargetNeutral$40.00Low
10/17/2018Cantor FitzgeraldReiterated RatingBuy$53.00Low
10/14/2018Credit Suisse GroupSet TargetHold$40.00Low
10/9/2018MorningstarSet TargetNeutral$46.00Low
10/4/2018Cantor FitzgeraldSet TargetBuy$45.00Low
10/4/2018Independent ResearchSet TargetNeutral$48.00Low
10/1/2018JPMorgan Chase & Co.Set TargetBuy$46.00Low
9/27/2018MorningstarSet TargetBuy$46.00Low
9/26/2018BarclaysReiterated RatingNeutral$40.00Low
9/26/2018Cantor FitzgeraldSet TargetBuy$45.00Low
9/13/2018Morgan StanleySet TargetBuy$45.00Medium
9/13/2018Cantor FitzgeraldSet TargetBuy$45.00Medium
9/10/2018JPMorgan Chase & Co.Set TargetBuy$42.00Medium
9/7/2018BMO Capital MarketsBoost TargetOutperform$47.00Medium
9/6/2018Credit Suisse GroupSet TargetHold$40.00Low
9/6/2018Morgan StanleySet TargetBuy$45.00Low
8/29/2018BarclaysSet TargetNeutral$40.00Low
8/29/2018Morgan StanleySet TargetBuy$45.00Low
8/28/2018Credit Suisse GroupSet TargetNeutral$40.00Low
8/28/2018The Goldman Sachs GroupReiterated RatingNeutral$45.00Low
8/28/2018MorningstarSet TargetBuy$46.00Low
8/27/2018BMO Capital MarketsReiterated RatingBuy$44.00Low
8/27/2018Cantor FitzgeraldSet TargetBuy$45.00High
8/23/2018JPMorgan Chase & Co.Reiterated RatingBuy$42.00Low
8/23/2018BarclaysBoost TargetEqual Weight ➝ Neutral$38.00 ➝ $40.00Low
8/23/2018Morgan StanleySet TargetOverweight ➝ Buy$43.00 ➝ $45.00Low
8/21/2018Deutsche Bank AktiengesellschaftSet TargetBuy$42.00 ➝ $45.00Low
8/13/2018Cantor FitzgeraldSet TargetBuy$45.00Low
8/10/2018SunTrust BanksBoost TargetHold$41.00Low
8/8/2018MorningstarSet TargetBuy$45.00Low
8/1/2018Bank of AmericaBoost TargetBuy ➝ Buy$42.00 ➝ $43.00Low
8/1/2018The Goldman Sachs GroupReiterated RatingNeutral$42.00Low
8/1/2018BMO Capital MarketsBoost TargetOutperform ➝ Outperform$42.00 ➝ $44.00Medium
8/1/2018Credit Suisse GroupBoost TargetNeutral ➝ Neutral$39.00 ➝ $40.00Medium
7/31/2018Jefferies Financial GroupSet TargetNeutral$39.00High
7/31/2018JPMorgan Chase & Co.Reiterated RatingBuyHigh
7/31/2018Credit Suisse GroupSet TargetHold$39.00High
7/31/2018Cantor FitzgeraldSet TargetBuy$45.00High
7/19/2018BMO Capital MarketsReiterated RatingBuy$42.00Low
7/18/2018JPMorgan Chase & Co.Reiterated Rating$37.66Medium
7/18/2018Cantor FitzgeraldSet TargetBuy$45.00Low
7/15/2018Jefferies Financial GroupSet TargetHold$39.00Low
7/12/2018Credit Suisse GroupSet TargetNeutral$39.00Low
7/11/2018Cantor FitzgeraldSet TargetBuy$45.00Low
7/11/2018JPMorgan Chase & Co.Reiterated RatingBuy$42.00Low
7/9/2018Jefferies Financial GroupReiterated RatingNeutral$39.00Medium
6/13/2018Cantor FitzgeraldSet TargetBuy$45.00Low
6/11/2018Morgan StanleyReiterated RatingBuy$43.00Low
6/11/2018Credit Suisse GroupSet TargetNeutral$39.00Low
6/7/2018Cantor FitzgeraldInitiated CoverageOverweight$45.00Low
5/30/2018Societe GeneraleReiterated RatingNeutral$39.00Low
5/18/2018Credit Suisse GroupReiterated RatingNeutral$39.00Low
5/14/2018Jefferies Financial GroupReiterated RatingNeutral$39.00Low
5/8/2018JPMorgan Chase & Co.Set TargetBuy$42.00Low
5/3/2018DZ BankReiterated RatingSellLow
5/2/2018MorningstarSet TargetBuy$43.50Low
5/2/2018BMO Capital MarketsLower TargetOutperform ➝ Outperform$43.00 ➝ $42.00Low
5/2/2018JPMorgan Chase & Co.Reiterated RatingBuy$42.00Medium
4/13/2018Jefferies Financial GroupSet TargetHold$38.00Low
4/12/2018CitigroupReiterated RatingSellMedium
4/11/2018Berenberg BankReiterated RatingNeutral$37.00Low
4/5/2018BarclaysDowngradeOverweight ➝ Equal Weight$41.00 ➝ $38.00Medium
4/2/2018BMO Capital MarketsSet TargetBuy$43.00Medium
(Data available from 4/1/2018 forward)

News Sentiment Rating

0.36 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 15 very positive mentions
  • 67 positive mentions
  • 10 negative mentions
  • 5 very negative mentions
  • 18 very positive mentions
  • 42 positive mentions
  • 13 negative mentions
  • 3 very negative mentions
  • 25 very positive mentions
  • 40 positive mentions
  • 10 negative mentions
  • 3 very negative mentions
  • 28 very positive mentions
  • 29 positive mentions
  • 5 negative mentions
  • 4 very negative mentions
  • 48 very positive mentions
  • 31 positive mentions
  • 11 negative mentions
  • 13 very negative mentions
  • 33 very positive mentions
  • 38 positive mentions
  • 14 negative mentions
  • 9 very negative mentions
  • 36 very positive mentions
  • 44 positive mentions
  • 14 negative mentions
  • 8 very negative mentions
  • 43 very positive mentions
  • 39 positive mentions
  • 12 negative mentions
  • 21 very negative mentions

Current Sentiment

  • 43 very positive mentions
  • 39 positive mentions
  • 12 negative mentions
  • 21 very negative mentions

Recent Stories by Sentiment

Pfizer logo
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Read More

Today's Range

Now: $40.80
Low: $40.28
High: $40.83

50 Day Range

MA: $41.98
Low: $39.39
High: $45.07

52 Week Range

Now: $40.80
Low: $39.23
High: $56.32


23,393,576 shs

Average Volume

22,347,270 shs

Market Capitalization

$230.29 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Pfizer?

The following Wall Street analysts have issued reports on Pfizer in the last twelve months: Atlantic Securities, Bank of America Co., Barclays PLC, Berenberg Bank, BMO Capital Markets, Cantor Fitzgerald, Citigroup Inc., Credit Suisse Group AG, Daiwa Capital Markets, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for PFE.

What is the current price target for Pfizer?

16 Wall Street analysts have set twelve-month price targets for Pfizer in the last year. Their average twelve-month price target is $50.38, suggesting a possible upside of 23.5%. Cantor Fitzgerald has the highest price target set, predicting PFE will reach $75.00 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of $40.00 for Pfizer in the next year.
View the latest price targets for PFE.

What is the current consensus analyst rating for Pfizer?

Pfizer currently has 9 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PFE, but not buy more shares or sell existing shares.
View the latest ratings for PFE.

What other companies compete with Pfizer?

How do I contact Pfizer's investor relations team?

Pfizer's physical mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company's listed phone number is (212) 733-2323. The official website for Pfizer is www.pfizer.com. Learn More about contacing Pfizer investor relations.